| Income Taxes (Details Narrative) - USD ($) | 12 Months Ended | |
|---|---|---|
| Dec. 31, 2018 | Dec. 31, 2017 | |
| Corporate tax rate | 21.00% | 34.00% | 
| Income tax description | On December 22, 2017, the Tax Cuts and Jobs Act ("The Act"), was signed into law by President Trump. The Act includes a number of provisions, including the lowering of the U.S. corporate tax rate from 35 percent to 21 percent, effective January 1, 2018 and the establishment of a territorial-style system for taxing foreign-source income of domestic multinational corporations. | |
| Provisional decrease in deferred tax assets | $ 4,935,000 | |
| Deferred tax assets, valuation allowance | $ 14,504,000 | 10,574,000 | 
| Valuation allowance, deferred tax asset, increase (decrease), amount | 3,900,000 | |
| Operating loss carryforwards | 50,400,000 | |
| Tax benefit | (506,920) | $ (356,956) | 
| Prior to January 1, 2018 [Member] | ||
| Operating loss carryforwards | $ 38,000,000 | |
| Operating loss carryforwards expiration date description | expire at various dates beginning in 2033 | |
| After January 1, 2018 [Member] | ||
| Operating loss carryforwards | $ 12,000,000 | |
| Percentage of utilization of limited current tear income | 80.00% | |
| Federal and State Research and Development Tax Credit Carryforwards [Member] | ||
| Tax credit carryforward, amount | $ 1,384,000 | |
| X | ||||||||||
| 
- Definition Operating Loss Carryforwards Expiration Date Description. No definition available. 
 | 
| X | ||||||||||
| 
- Definition Percentage of utilization of limited current tear income. No definition available. 
 | 
| X | ||||||||||
| 
- Definition Provision decrease in deferred tax assets. No definition available. 
 | 
| X | ||||||||||
| 
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef 
 | 
| X | ||||||||||
| 
- Definition Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef 
 | 
| X | ||||||||||
| 
- Definition A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef 
 | 
| X | ||||||||||
| 
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef 
 | 
| X | ||||||||||
| 
- Definition Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef 
 | 
| X | ||||||||||
| 
- Definition The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef 
 | 
| X | ||||||||||
| 
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef 
 | 
| X | ||||||||||
| 
- Details 
 | 
| X | ||||||||||
| 
- Details 
 | 
| X | ||||||||||
| 
- Details 
 |